tradingkey.logo

Transmedics Group Inc

TMDX
View Detailed Chart
135.060USD
+5.460+4.21%
Close 02/06, 16:00ETQuotes delayed by 15 min
4.61BMarket Cap
49.90P/E TTM

Transmedics Group Inc

135.060
+5.460+4.21%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.21%

5 Days

+0.81%

1 Month

+1.80%

6 Months

+13.69%

Year to Date

+11.02%

1 Year

+83.76%

View Detailed Chart

Key Insights

Transmedics Group Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 48 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 146.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Transmedics Group Inc's Score

Industry at a Glance

Industry Ranking
48 / 205
Overall Ranking
138 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Transmedics Group Inc Highlights

StrengthsRisks
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 372.44% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 49.90, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.04M shares, decreasing 12.69% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 8.24K shares of this stock.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
146.000
Target Price
+12.65%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Transmedics Group Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Transmedics Group Inc Info

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEOHassanein (Waleed H)
Websitehttps://www.transmedics.com/
KeyAI